genebycell
Genebycell is a biotechnology company that specializes in the development of gene therapy products. The company was founded in 2016 and is headquartered in Beijing, China. Genebycell's primary focus is on the research and development of gene therapy for the treatment of genetic disorders. The company's approach involves the use of advanced gene editing technologies, such as CRISPR-Cas9, to correct genetic mutations that cause diseases.
The company's pipeline includes several gene therapy candidates for various genetic disorders, including muscular dystrophy, cystic
Genebycell collaborates with academic institutions, research organizations, and pharmaceutical companies to advance its gene therapy programs.